ERβ agonists also exert a tumor suppressor activity in WM115 (BRAF V600D-mutant) cells, while they fail to reduce cell proliferation in A375 and WM1552 (BRAF V600E-mutant) cells. This evidence concerns the gene BRAF and neoplasm.